Nurses often get involved with patients with multiple sclerosis (MS) before their diagnosis and then work to educate them on the disease and its care, said Amy Perrin Ross, APN, MSN, CNRN, MSCN, Neuroscience Program Coordinator at Loyola University Medical Center.
Nurses often get involved with patients with multiple sclerosis (MS) before their diagnosis and then work to educate them on the disease and its care, said Amy Perrin Ross, APN, MSN, CNRN, MSCN, Neuroscience Program Coordinator at Loyola University Medical Center.
Transcript
How do MS nurses fit into the overall care team and when do they get introduced into a patient’s MS management after diagnosis?
One of the diagrams that we'll be showing in the presentation shows a large Starburst with the patient in the center of the starburst and each of the different prongs, representing many of the members of the care team. The MS nurse is one of those members.
And interesting you asked about out how to nurses get introduced to the management after diagnosis, and in fact many of us are involved well before the diagnosis. Nurse practitioners and advanced practice providers are people that may be seeing a patient to rule out a diagnosis or rule in the diagnosis of multiple sclerosis. And it may be the nurse practitioner or advanced practice provider who is really working the patient up and talking to them about the diagnosis of MS. So, we're often very much involved from the beginning.
If we have physician collaborators, and there are general MS nurses who are not necessarily advanced practice providers, they can get involved in a number of ways. I know I always like to introduce myself to the patients early on. Certainly, while they're being worked up by the neurologist while tests are being recommended for them. I try to talk to them about what the tests are. For example, a lumbar puncture: Why would we want to do that? What are we looking for? Talk about what we're looking for in the cerebral spinal fluid, and what some of those diagnostic markers may or may not mean.
Also talk to them about MRIs. Now a lot of people are very familiar with MRI and some people are scared of MRIs and a fear of claustrophobia and things. But I talked to them about specifically what we're looking for in an MRI, why we may want to image the cervical spine and perhaps the thoracic spine, as well. And just talk to them about some of the other blood tests that we might be doing looking to rule out other autoimmune diseases that may be mimicking MS. So, I sort of tried to set the stage there.
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More